Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.


Updates from The Motley Fool

Latest updates on Novartis from Fool.com.


Stock Performance

NVS vs. S&P 500 | 2 Year Performance
View Interactive NVS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novartis.
Current Price: $81.18
Prev Close: $79.59
Open: $81.20
Bid: $80.01
Ask: $82.99
Day's Range: $80.91 - $81.59
52wk Range: $69.90 - $106.84
Volume: 2,548,407
Avg Vol 2,020,483
Market Cap: $194.50B
P/E (ttm): 21.51
EPS (ttm): $0.00
Div & Yield: $2.67 (2.9%)

Company Rating

What our community thinks about Novartis.
CAPS Rating 4 out of 5
 
1453 Outperform
45 Underperform
CAPS All Stars
 
395 Outperform
12 Underperform

How do you think Novartis will perform against the market?



You pick for Novartis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Joseph Jimenez, CEO

77% Approve

Based on 61 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novartis.

Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers